Literature DB >> 25542046

Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.

Luis Martínez-Martínez1, Juan José González-López2.   

Abstract

The most important mechanism of carbapenem resistance in Enterobacteriaceae is the production of carbapenemases, although resistance can also result from the synergistic activity between AmpC-type or (to a lesser extent) extended-spectrum beta-lactamases combined with decreased outer membrane permeability. Three major molecular classes of carbapenemases are recognized: A, B and D. Classes A and D are serine-beta-lactamases, whereas class B are metallo-beta-lactamases (their hydrolytic activity depends on the presence of zinc). In addition to carbapenems, carbapenemases also hydrolyze other beta-lactams, but the concrete substrate profile depends on the enzyme type. In general terms, class A enzymes are to some extent inhibited by clavulanic acid, and class B enzymes do not affect monobactams and are inhibited by zinc chelators. Given Enterobacteriaceae producing carbapenemases usually also contain gene coding for other mechanisms of resistance to beta-lactams, it is not unusual for the organisms to present complex beta-lactam resistance phenotypes. Additionally, these organisms frequently contain other genes that confer resistance to quinolones, aminoglycosides, tetracyclines, sulphonamides and other families of antimicrobial agents, which cause multiresistance or even panresistance. Currently, the most important type of class A carbapenemases are KPC enzymes, whereas VIM, IMP and (particularly) NDM in class B and OXA-48 (and related) in class D are the more relevant enzymes. Whereas some enzymes are encoded by chromosomal genes, most carbapenemases are plasmid-mediated (with genes frequently located in integrons), which favors the dissemination of the enzymes. Detailed information of the genetic platforms and the context of the genes coding for the most relevant enzymes will be presented in this review.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Beta-lactams; Betalactámicos; Carbapenemasas; Carbapenemases; Enterobacteriaceae; Enterobacterias; Multiresistance; Multirresistencia

Mesh:

Substances:

Year:  2014        PMID: 25542046     DOI: 10.1016/S0213-005X(14)70168-5

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  20 in total

1.  Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.

Authors:  Vlatko Stojanoski; Dar-Chone Chow; Bartlomiej Fryszczyn; Liya Hu; Patrice Nordmann; Laurent Poirel; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  Biochemistry       Date:  2015-05-14       Impact factor: 3.162

2.  Improved blood culture workflow for faster identification of KPC-producing Enterobacterales.

Authors:  Bruna Mara Silva Seco; Juliana Coutinho Campos; Darlan Augusto da Costa Rocha; Aline Valerio de Lima; Fernanda Filomena de Oliveira; Mara Elisa Borsato Lemo; Suely Carlos Ferreira Sampaio; Jorge Luiz Mello Sampaio
Journal:  Braz J Microbiol       Date:  2018-12-06       Impact factor: 2.476

3.  Spectroscopic analysis and docking simulation on the recognition and binding of TEM-1 β-lactamase with β-lactam antibiotics.

Authors:  Jianting Yang; Qian Li; Liujiao Bian
Journal:  Exp Ther Med       Date:  2017-07-31       Impact factor: 2.447

Review 4.  Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.

Authors:  Claire Amaris Hobson; Gautier Pierrat; Olivier Tenaillon; Stéphane Bonacorsi; Béatrice Bercot; Ella Jaouen; Hervé Jacquier; André Birgy
Journal:  Antimicrob Agents Chemother       Date:  2022-08-18       Impact factor: 5.938

Review 5.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

6.  KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region.

Authors:  Jacqueline Findlay; Katie L Hopkins; Michel Doumith; Danièle Meunier; Camilla Wiuff; Robert Hill; Rachel Pike; Richard Loy; Nazim Mustafa; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2016-02-03       Impact factor: 5.790

7.  Detection of carbapenemase producing enterobacteria using an ion sensitive field effect transistor sensor.

Authors:  Stathis D Kotsakis; Georgios Miliotis; Eva Tzelepi; Leonidas S Tzouvelekis; Vivi Miriagou
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

8.  Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections.

Authors:  Antonio Galiana; Javier Coy; Adelina Gimeno; Noemi Marco Guzman; Francisco Rosales; Esperanza Merino; Gloria Royo; Juan Carlos Rodríguez
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

9.  Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.

Authors:  Rong Zhang; Ning Dong; Yonglu Huang; Hongwei Zhou; Miaomiao Xie; Edward Wai-Chi Chan; Yanyan Hu; Jiachang Cai; Sheng Chen
Journal:  Emerg Microbes Infect       Date:  2018-07-09       Impact factor: 7.163

10.  The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia.

Authors:  Nadezhda K Fursova; Eugeny I Astashkin; Anastasia I Knyazeva; Nikolay N Kartsev; Ekaterina S Leonova; Olga N Ershova; Irina A Alexandrova; Natalia V Kurdyumova; Svetlana Yu Sazikina; Nikolay V Volozhantsev; Edward A Svetoch; Ivan A Dyatlov
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-11-02       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.